Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Five Factors Linked to Infections Following Orthopedic Surgery

By HospiMedica International staff writers
Posted on 05 Mar 2019
A new study links diabetes, obesity, smoking, prolonged surgery, and low pre-surgical albumin levels to an increased risk of developing surgical site infection (SSI).

Researchers at Xinjiang Medical University (XJMU; China) and the First Hospital of Jilin University (Changchun, China) conducted a retrospective study involving 4,818 patients (60 years of age or older) who underwent elective orthopedic surgery between January 2014 and September 2017. More...
The patients' demographics, characteristics of disease, surgery‐related variables, and laboratory examination indexes were inquired and documented, and SSI was identified from the patients' medical records.

The results revealed that 74 patients developed SSIs within one year, for an overall incidence rate of 3.64%. Staphylococcus aureus and coagulase‐negative staphylococci were the most common causative pathogens; half of S. aureus SSIs were caused by Methicillin‐resistant Staphylococcus aureus (MRSA). Five risk factors were identified to be independently associated with SSI, including diabetes mellitus, morbid obesity, tobacco smoking, surgical duration higher than the 75th percentile, and serum albumin levels lower than 35 g/L. The study was published on February 20, 2019, in International Wound Journal.

“The purposes of this study were to investigate the incidence of surgical site infection following geriatric elective orthopedic surgeries, and identify the associated risk factors,” concluded lead author Zhiquan Liang, MD, of the First Hospital of Jilin University, and colleagues. “We recommend the optimization of modifiable risk factors such as morbid obesity, tobacco smoking, and lower serum albumin level prior to surgeries to reduce the risk of SSI.”

SSI is the most common postoperative complication, occurring in approximately 2-5% of patients who undergo clean extra-abdominal surgeries, such as thoracic and orthopedic surgery, and in up to 20% of patients who undergo intra-abdominal surgery interventions. Besides the pain and suffering to patients, SSI could lead to catastrophic health expenditure and impoverishment to patients who are required to pay for their own treatment, and a significant financial burden on healthcare providers.

Related Links:
Xinjiang Medical University
First Hospital of Jilin University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.